Fragrances creator Symrise GmbH & Co KG announces that the company acquires Kaden Biochemicals Gmbh.
The spectrum of Kaden's services is an ideal complement to the Symrise portfolio; new presence on the dynamic nutraceuticals market.
Symrise is expanding its position as one of the world's four largest partners of the international fragrance, cosmetics and food industry. By acquiring Kaden Biochemicals GmbH, the corporation continues its pattern of growth in the fields of fragrances, flavours and cosmetic ingredients.
Kaden Biochemicals was an owner-operated company in which Heinrich Kaden holds 90% of the stock. In their search for new ownership, the management at Kaden decided in favor of Symrise, which now owns Kaden Biochemicals completely.
“Symrise was always my partner of choice when we were looking for a successor for my business. I am confident that these two companies suit each other perfectly in terms of their product portfolio,” said Heinrich Kaden.
“This acquisition gives us a good position on the highly attractive market for functional food and nutraceuticals. As a result, we can now offer a much broader spectrum, and we can present ourselves even more strongly as a source of comprehensive sensory solutions for nearly every challenge on the market,” stated Dr. Gerold Linzbach, CEO at Symrise.
Hamburg based Kaden Biochemicals has its headquarters in Hamburg. It develops and produces high purity active ingredients from plant material. The company is regarded as a major specialist in this area, and it is most active on the German and American markets.
Symrise stands for the creative symbiosis of two long-established companies and their new union as an ambitious, future-oriented corporation. It represents the fruitful and successful collaboration with clients and partners.